The $25 billion dialysis industry faces transformation as it moves from offering a profitable niche service to what insurers see as a cost center under the population health-management approach.
Hospital groups and dialysis and home care providers are warning that a five-star rating system the CMS plans to apply to them as early as this fall is more likely to confuse consumers than help them meaningfully compare providers' quality and safety.
Germany's Fresenius Medical Care agreed to buy a majority stake in Tacoma, Wash.-based Sound Inpatient Physicians for about $600 million, part of a drive to offer additional services linked to its core business of kidney dialysis.
Federal health regulators are allowing a U.S. medical supply company to import saline solution from its Spanish plant to address a national shortage of the hospital staple.
Dialysis providers welcomed a 2014 reprieve in Medicare payment cuts for the treatment of end-stage renal disease and signaled they'll keep up their efforts to change the underlying policy.
In what is likely to be a relief to dialysis providers, the CMS decided to phase in the controversial payment cut to dialysis providers over a three- to four-year period.
U.S. regulators have issued a third warning this year for German healthcare group Fresenius to improve procedures at its sites, this time a blood bag manufacturing plant in Puerto Rico.
U.S. Renal Care has completed its acquisition of Ambulatory Services of America after first announcing in June the planned merger of the dialysis companies.
Hospital medicine and critical-care company Cogent Healthcare has named Dean Weiland president and CEO and a member of its board.
Dialysis service providers would see a 9.4% cut to their Medicare pay in 2014 under a proposed CMS update issued late Monday.
U.S. Renal Care will acquire Ambulatory Services of America under a definitive merger agreement that the Plano, Texas-based dialysis company announced Tuesday.
Tim Weaver, an 18-year-old college student who lives in Naperville, Ill., is one of the estimated 30,000 people in the U.S. who rely on intravenous nutrition products to keep them alive.